Swiss drugmaker Roche on Friday got a positive recommendation from a key European panel for its immunotherapy Tecentriq mixed with Avastin against liver cancer, likely clearing the way for the ...
Relief Therapeutics said on Tuesday that more people who received a 50-year-old drug that the Swiss company is seeking to re-purpose against COVID-19 were alive beyond 60 days than were those who did ...
Giselle Mosnaim, MD, an allergist and immunologist at Endeavor Health, discusses Rhapsido® (remibrutinib), a new FDA-approved oral therapy for chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback